Foundation Medicine, Inc. 4
4 · Foundation Medicine, Inc. · Filed May 3, 2017
Insider Transaction Report
Form 4
Daly David
Chief Commercial Officer
Transactions
- Award
Common Stock
2017-05-01$35.80/sh+24,550$878,890→ 123,132 total
Footnotes (1)
- [F1]Represents restricted stock units issued pursuant to a Restricted Stock Unit Award Agreement and the Issuer's 2013 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in equal quarterly installments over a three-year period with the first installment vesting on August 1, 2017.